AI-designed OCD drug set to be tested on humans

Would you trust artificial intelligence (AI) enough to consume a drug made by it? Researchers at Oxford-based biotech company — Exscientia — have reportedly used AI tools to create a drug that is now ready to enter clinical human trials.

According to Engadget, the drug, known as DSP-1181, has been created using algorithms that scanned through compounds and checked against the database of parameters such as patient’s genetic factors.